Rheumatology
News
Tocilizumab shortage continues as pandemic wears on
Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory...
News
No higher risk of rheumatic and musculoskeletal disease flares seen after COVID-19 vaccination
The findings may help rheumatologists to convince patients to get Pfizer and Moderna shots.
News
FDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 years
Anifrolumab, a monoclonal antibody against type 1 interferon receptor, improved overall disease activity in patients with SLE on standard therapy...
News
COVID-19 vaccination does not increase risk of flare in patients with lupus
An international web-based survey found a very low rate of medically confirmed flare post COVID vaccination in nearly 700 participants.
Conference Coverage
Patients on methotrexate show T-cell response to Pfizer vaccine
Despite poor antibody response to the mRNA COVID-19 vaccine, cellular immunity was generated in patients taking methotrexate, new research shows...
News
New ACR guidance recommends COVID-19 vaccination in RMD patients
Conference Coverage
Novel study links air pollution to increased risk of rheumatoid arthritis flares
Increased air pollution parallels increased RA flares in a novel study undertaken in an industrial city.
Conference Coverage
EULAR COVID-19 recommendations set for update
Conclusions drawn from a systematic literature review largely appear to reinforce the recommendations that have already been made but need further...
News
Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseases
Patients who take methotrexate or rituximab seem to be especially vulnerable.
News
FDA panel narrowly backs avacopan approval
The FDA is mulling whether to approve avacopan for ANCA-associated vasculitis based largely on a single trial about which the agency staff has...